🇯🇵 Ditropan Xl in Japan

PMDA authorised Ditropan Xl on 27 March 2023

Marketing authorisation

PMDA — authorised 27 March 2023

  • Marketing authorisation holder: Hisamitsu Pharmaceutical Co., Inc.
  • Status: approved

Ditropan Xl in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in Japan

Frequently asked questions

Is Ditropan Xl approved in Japan?

Yes. PMDA authorised it on 27 March 2023.

Who is the marketing authorisation holder for Ditropan Xl in Japan?

Hisamitsu Pharmaceutical Co., Inc. holds the Japanese marketing authorisation.